Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Kursexplosion von 383 % seit November und massiver Solana-Outperformer!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1CYK3 | ISIN: GB00B50P5B53 | Ticker-Symbol: BYA1
Frankfurt
22.01.25
08:07 Uhr
0,014 Euro
-0,008
-35,71 %
1-Jahres-Chart
QUANTUM BLOCKCHAIN TECHNOLOGIES PLC Chart 1 Jahr
5-Tage-Chart
QUANTUM BLOCKCHAIN TECHNOLOGIES PLC 5-Tage-Chart
PR Newswire
292 Leser
Artikel bewerten:
(1)

Quantum Blockchain Technologies Plc - Amendment and Grant of Share Options

Finanznachrichten News

Quantum Blockchain Technologies Plc - Amendment and Grant of Share Options

PR Newswire

LONDON, United Kingdom, December 11

11 December 2024

Quantum Blockchain Technologies Plc

( "QBT" or "the Company")

Amendment and Grant of Options

The Board of Quantum Blockchain Technologies Plc (AIM:QBT) wishes to inform its shareholders regarding the amendment of the exercise date of 52 million already granted Options over QBT's ordinary shares of 0.25 pence each in the Company (Options), as follows:

- 28,500,000 Options with exercise price at 5p:

Number Options

Old Exercise Date
(on or before)

New Exercise Date
(on or before)

5,000,000

15/12/2024

06/05/2026

5,000,000

06/05/2025

06/05/2026

5,000,000

22/05/2025

06/05/2026

13,500,000

25/05/2025

06/05/2026

- 23,500,000 Options with exercise price at 10p:

Number Options

Old Exercise Date
(on or before)

New Exercise Date
(on or before)

2,500,000

15/12/2024

06/05/2026

5,000,000

06/05/2025

06/05/2026

5,000,000

22/05/2025

06/05/2026

11,000,000

25/05/2025

06/05/2026

For all these Options the new exercise date is on or before 6 May 2026.

Notably, within the above Options are included the following ones, issued to the Non-Executive Directors (the "NED Options"):

- Peter Fuhrman

  • 2,500,000 Options with exercise price at 5p and (previous) exercise date on or before 15 December 2024
  • 2,500,000 Options with exercise price at 10p and (previous) exercise date on or before 15 December 2024

- Mark Trafeli

  • 2,500,000 Options with exercise price at 5p and (previous) exercise date on or before 15 December 2024

Moreover, the Company has also issued new 2,000,000 Options to a consultant, as follows:

- 1,000,000 Options with exercise price at 5p and exercise date on or before 06 May 2026

- 1,000,000 Options with exercise price at 10p and exercise date on or before 06 May 2026

The Company now has outstanding Options over 134,500,000 Ordinary Shares exercisable at 5 pence and Options over 134,500,000 Ordinary Shares, exercisable at 10 pence. These Options expire during 2026. The number of Options still available to be issued (as duly authorised at the General Meeting held on 6 May 2022) is 31,000,000.

Related Party Transaction

As 7,500,000 Options are held by Mark Trafeli and Peter Fuhrman, both non-executive directors of the Company, the extension to the expiry date of the NED Options is considered to be a related party transaction pursuant to AIM Rule 13 of the AIM Rules for Companies.

Accordingly, Francesco Gardin, being the director independent of the extension of the NED Options considers, having consulted with the Company's nominated adviser, that the terms of extension of the NED Options is fair and reasonable in so far as ordinary shareholders are concerned.

For further information please contact:

Quantum Blockchain Technologies Plc
Francesco Gardin, CEO and Executive Chairman +39 335 296573

SP Angel Corporate Finance (Nominated Adviser & Broker)
Jeff Keating +44 (0)20 3470 0470

Leander (Financial PR)
Christian Taylor-Wilkinson +44 (0) 7795 168 157

About Quantum Blockchain Technologies Plc

QBT (AIM: QBT) is an AIM listed investment company with a strategic focus on technology related investments, including a special regard towards Quantum Computing, Blockchain, Cryptocurrencies and AI sectors. The Company has an aggressive R&D and investment programme in the dynamic world of Blockchain Technology, which includes cryptocurrency mining and other advanced blockchain applications.

1.

Detailsofthepersondischarging managerialresponsibilities/personcloselyassociated

a)

Name:

Peter Fuhrman

2.

Reasonforthenotification

a)

Position/status:

Non-Executive Director

b)

Initialnotification/Amendment:

Amendment

3.

Detailsoftheissuer,emissionallowancemarketparticipant,auctionplatform,auctioneeror auction monitor

a)

Name:

QuantumBlockchainTechnologiesPlc

b)

LEI:

213800FC5DEC582CRZ89

4.

Detailsofthetransaction(s):sectiontoberepeatedfor(i)eachtypeofinstrument;(ii)each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

a)

Description of the financial instrument,typeofinstrument: Identification code:

Warrants on Ordinarysharesof0.25peach

b)

Natureofthetransaction:

Extensionofexercise date

c)

Price(s)andvolume(s):

Price(s) Volume(s)

5p2,500,000

10p 2,500,000

d)

Aggregatedinformation: Aggregated volume: Price:

Singletransactionasin4c)above Price(s) Volume(s)

5p2,500,000

10p 2,500,000

e)

Dateofthetransaction:

10 December2024

f)

Placeofthetransaction:

Outsideofatradingvenue

1.

Detailsofthepersondischarging managerialresponsibilities/personcloselyassociated

a)

Name:

Mark Michael Trafeli

2.

Reasonforthenotification

a)

Position/status:

Non-Executive Director

b)

Initialnotification/Amendment:

Amendment

3.

Detailsoftheissuer,emissionallowancemarketparticipant,auctionplatform,auctioneeror auction monitor

a)

Name:

QuantumBlockchainTechnologiesPlc

b)

LEI:

213800FC5DEC582CRZ89

4.

Detailsofthetransaction(s):sectiontoberepeatedfor(i)eachtypeofinstrument;(ii)each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

a)

Description of the financial instrument,typeofinstrument: Identification code:

Warrants on Ordinarysharesof0.25peach

b)

Natureofthetransaction:

Extensionofexercise date

c)

Price(s)andvolume(s):

Price(s) Volume(s)

5p2,500,000

d)

Aggregatedinformation: Aggregated volume: Price:

Singletransactionasin4c)above Price(s) Volume(s)

5p2,500,000

e)

Dateofthetransaction:

10December2024

f)

Placeofthetransaction:

Outsideofatradingvenue




© 2024 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.